Compound class:
Synthetic organic
Comment: MI-3 inhibits the interaction between MLL oncoproteins (re-arranged lysine (K)-specific methyltransferases) and the tumour suppressor protein menin (MEN1, O00255) [1]. MI-3 represents a novel molecular mechanism with potential application in the treatment of aggressive leukemias with MLL rearrangements.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
4-[4-(5,5-dimethyl-4H-1,3-thiazol-2-yl)piperazin-1-yl]-6-propan-2-ylthieno[2,3-d]pyrimidine |
Database Links ![]() |
|
CAS Registry No. | 1271738-59-0 |
GtoPdb PubChem SID | 249565783 |
PubChem CID | 51001299 |
Search Google for chemical match using the InChIKey | FUGQNAUKABUDQI-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | FUGQNAUKABUDQI |
UniChem Compound Search for chemical match using the InChIKey | FUGQNAUKABUDQI-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | FUGQNAUKABUDQI-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
MI-3 (links to external site)
Cat. No. HY-15223 |